Estrogen enhances tumor growth and angiogenesis indirectly via mediation of bone marrow‑derived cells as well as directly through stimulation of tumor and endothelial cells

Zhuo,Yingchen; Li,Xueqian; Zheng,Qiaowei; Fan,Xingjun; Ma,Wenbing; Chen,Jingguo; Zhao,Xue; Zhao,Peipei; Liu,Xuanlin; Tang,Fengru; Cheng,Kai; Feng,Weiyi

doi:10.3892/or.2018.6631

Estrogen enhances tumor growth and angiogenesis indirectly via mediation of bone marrow‑derived cells as well as directly through stimulation of tumor and endothelial cells

Authors:
- Yingchen Zhuo
- Xueqian Li
- Qiaowei Zheng
- Xingjun Fan
- Wenbing Ma
- Jingguo Chen
- Xue Zhao
- Peipei Zhao
- Xuanlin Liu
- Fengru Tang
- Kai Cheng
- Weiyi Feng
View Affiliations

Affiliations: Department of Pharmacy, The First Afﬁliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi 710061, P.R. China, Department of Pathology, Case Western Reserve University, Cleveland, OH 4410, USA
Published online on: August 7, 2018 https://doi.org/10.3892/or.2018.6631
Pages: 2147-2156

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Estradiol (E2) is a prime culprit for enhancing the progression of female hormone‑related cancers. Bone marrow‑derived cells (BMDCs) have been found to play a pivotal role in tumor growth. Estrogen receptors (ERs) are also found on certain subtypes of BMDCs, in addition to endothelial cells (ECs) and certain tumor cells. However, the role of BMDCs in E2‑induced tumor biology is still unclear. Thus, the effects of E2 on ER‑negative 4T1 breast cancer growth, the mobilization and recruitment of BMDCs, and interactions among BMDCs, ECs, and 4T1 cells were investigated. The results showed that E2 potentiated 4T1 tumor growth and angiogenesis in mice subjected to sham operation, ovariectomy (OVX), or OVX and E2 replacement treatment. E2 supplementation in mice with OVX upregulated the transcription of stromal cell‑derived factor‑1 (SDF‑1) mRNA in tumor tissues and enhanced the recruitment of BMDCs into tumor tissues in vivo. E2 deficiency significantly decreased proangiogenic CXCR4+, β3+, Sca‑1+ and CXCR4+β3+ BMDCs circulating in the peripheral blood. Cell‑based system analyses showed that E2 augmented the transcription of β3 mRNA in ECs, increased the adhesion of BMDCs to ECs. In addition, E2 enhanced the BMDC‑induced EC proliferation and migration, the BMDC‑induced 4T1 proliferation and the 4T1‑stimulated EC proliferation in addition to enhancing the proliferation of tumor cells and the migration of ECs in vitro. Therefore, E2 enhanced the growth of breast tumors by stimulating tumor cells and ECs directly, as well as by increasing proangiogenic BMDC mobilization and recruitment leading to augmentation of the tumor and EC functions indirectly by cell proliferation assay. These findings reveal a separate mechanism via which E2 promotes the growth of female hormone‑dependent tumors, which may be useful in explorations of new therapies for related cancers.

View Figures

View References

1	O'Lone R, Frith MC, Karlsson EK and Hansen U: Genomic targets of nuclear estrogen receptors. Mol Endocrinol. 18:1859–1875. 2004. View Article : Google Scholar : PubMed/NCBI
2	Deroo BJ and Korach KS: Estrogen receptors and human disease. J Clin Invest. 116:561–570. 2006. View Article : Google Scholar : PubMed/NCBI
3	Mauvais-Jarvis F, Clegg DJ and Hevener AL: The role of estrogens in control of energy balance and glucose homeostasis. Endocr Rev. 34:309–338. 2013. View Article : Google Scholar : PubMed/NCBI
4	Cui J, Shen Y and Li R: Estrogen synthesis and signaling pathways during aging: From periphery to brain. Trends Mol Med. 19:197–209. 2013. View Article : Google Scholar : PubMed/NCBI
5	Nelson ER, Wardell SE and McDonnell DP: The molecular mechanisms underlying the pharmacological actions of estrogens, SERMs and oxysterols: Implications for the treatment and prevention of osteoporosis. Bone. 53:42–50. 2013. View Article : Google Scholar : PubMed/NCBI
6	Ascenzi P, Bocedi A and Marino M: Structure-function relationship of estrogen receptor alpha and beta: Impact on human health. Mol Aspects Med. 27:299–402. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hamilton KJ, Arao Y and Korach KS: Estrogen hormone physiology: Reproductive findings from estrogen receptor mutant mice. Reprod Biol. 14:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
8	Björnström L and Sjöberg M: Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol Endocrinol. 19:833–842. 2005. View Article : Google Scholar : PubMed/NCBI
9	Santollo J and Daniels D: Multiple estrogen receptor subtypes influence ingestive behavior in female rodents. Physiol Behav. 152:431–437. 2015. View Article : Google Scholar : PubMed/NCBI
10	Yager JD and Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 354:270–282. 2006. View Article : Google Scholar : PubMed/NCBI
11	McGuire S: World cancer report 2014. Geneva, Switzerland: World health organization, international agency for research on cancer, WHO Press, 2015. Adv Nutr. 7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
12	Endogenous Hormones and Breast Cancer Collaborative Group, . Key TJ, Appleby PN, Reeves GK, Travis RC, Alberg AJ, Barricarte A, Berrino F, Krogh V, Sieri S, et al: Sex hormones and risk of breast cancer in premenopausal women: A collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 14:1009–1019. 2013. View Article : Google Scholar : PubMed/NCBI
13	Dunn BK, Wickerham DL and Ford LG: Prevention of hormone-related cancers: Breast cancer. J Clin Oncol. 23:357–367. 2005. View Article : Google Scholar : PubMed/NCBI
14	Losordo DW and Isner JM: Estrogen and angiogenesis: A review. Arterioscler Thromb Vasc Biol. 21:6–12. 2001. View Article : Google Scholar : PubMed/NCBI
15	Arnal JF, Fontaine C, Billon-Galés A, Favre J, Laurell H, Lenfant F and Gourdy P: Estrogen receptors and endothelium. Arterioscler Thromb Vasc Biol. 30:1506–1512. 2010. View Article : Google Scholar : PubMed/NCBI
16	Iyer V, Klebba I, McCready J, Arendt LM, Betancur-Boissel M, Wu MF, Zhang X, Lewis MT and Kuperwasser C: Estrogen promotes ER-negative tumor growth and angiogenesis through mobilization of bone marrow-derived monocytes. Cancer Res. 72:2705–2713. 2012. View Article : Google Scholar : PubMed/NCBI
17	Feng W, Madajka M, Kerr BA, Mahabeleshwar GH, Whiteheart SW and Byzova TV: A novel role for platelet secretion in angiogenesis: Mediating bone marrow-derived cell mobilization and homing. Blood. 117:3893–3902. 2011. View Article : Google Scholar : PubMed/NCBI
18	Murdoch C, Muthana M, Coffelt SB and Lewis CE: The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev Cancer. 8:618–631. 2008. View Article : Google Scholar : PubMed/NCBI
19	Rizvi AZ, Swain JR, Davies PS, Bailey AS, Decker AD, Willenbring H, Grompe M, Fleming WH and Wong MH: Bone marrow-derived cells fuse with normal and transformed intestinal stem cells. Proc Natl Acad Sci USA. 103:6321–6325. 2006. View Article : Google Scholar : PubMed/NCBI
20	Ruifrok WP, de Boer RA, Iwakura A, Silver M, Kusano K, Tio RA and Losordo DW: Estradiol-induced, endothelial progenitor cell-mediated neovascularization in male mice with hind-limb ischemia. Vasc Med. 14:29–36. 2009. View Article : Google Scholar : PubMed/NCBI
21	Hamada H, Kim MK, Iwakura A, Ii M, Thorne T, Qin G, Asai J, Tsutsumi Y, Sekiguchi H, Silver M, et al: Estrogen receptors alpha and beta mediate contribution of bone marrow-derived endothelial progenitor cells to functional recovery after myocardial infarction. Circulation. 114:2261–2270. 2006. View Article : Google Scholar : PubMed/NCBI
22	Péqueux C, Raymond-Letron I, Blacher S, Boudou F, Adlanmerini M, Fouque MJ, Rochaix P, Noël A, Foidart JM, Krust A, et al: Stromal estrogen receptor-alpha promotes tumor growth by normalizing an increased angiogenesis. Cancer Res. 72:3010–3019. 2012. View Article : Google Scholar : PubMed/NCBI
23	Ström JO, Theodorsson A, Ingberg E, Isaksson IM and Theodorsson E: Ovariectomy and 17β-estradiol replacement in rats and mice: A visual demonstration. J Vis Exp. 64:e40132012.
24	Feng W, McCabe NP, Mahabeleshwar GH, Somanath PR, Phillips DR and Byzova TV: The angiogenic response is dictated by beta3 integrin on bone marrow-derived cells. J Cell Biol. 183:1145–1157. 2008. View Article : Google Scholar : PubMed/NCBI
25	Houghton J, Stoicov C, Nomura S, Rogers AB, Carlson J, Li H, Cai X, Fox JG, Goldenring JR and Wang TC: Gastric cancer originating from bone marrow-derived cells. Science. 306:1568–1571. 2004. View Article : Google Scholar : PubMed/NCBI
26	Shaked Y and Voest EE: Bone marrow derived cells in tumor angiogenesis and growth: are they the good, the bad or the evil? Biochim Biophys Acta. 1796:1–4. 2009.PubMed/NCBI
27	Mahabeleshwar GH, Feng W, Phillips DR and Byzova TV: Integrin signaling is critical for pathological angiogenesis. J Exp Med. 203:2495–2507. 2006. View Article : Google Scholar : PubMed/NCBI
28	Melero-Martin JM and Dudley AC: Concise review: Vascular stem cells and tumor angiogenesis. Stem Cells. 29:163–168. 2011. View Article : Google Scholar : PubMed/NCBI
29	Sainz J and Sata M: CXCR4, a key modulator of vascular progenitor cells. Arterioscler Thromb Vasc Biol. 27:263–265. 2007. View Article : Google Scholar : PubMed/NCBI
30	Teicher BA and Fricker SP: CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res. 16:2927–2931. 2010. View Article : Google Scholar : PubMed/NCBI
31	Ahn GO, Tseng D, Liao CH, Dorie MJ, Czechowicz A and Brown JM: Inhibition of Mac-1 (CD11b/CD18) enhances tumor response to radiation by reducing myeloid cell recruitment. Proc Natl Acad Sci USA. 107:8363–8368. 2010. View Article : Google Scholar : PubMed/NCBI
32	De Francesco EM, Pellegrino M, Santolla MF, Lappano R, Ricchio E, Abonante S and Maggiolini M: GPER mediates activation of HIF1α/VEGF signaling by estrogens. Cancer Res. 74:4053–4064. 2014. View Article : Google Scholar : PubMed/NCBI
33	Heldring N, Pike A, Andersson S, Matthews J, Cheng G, Hartman J, Tujague M, Ström A, Treuter E, Warner M and Gustafsson JA: Estrogen receptors: How do they signal and what are their targets. Physiol Rev. 87:905–931. 2007. View Article : Google Scholar : PubMed/NCBI